Garcia-Carbonero's Lab
@GCarboneroLab
Followers
584
Following
1K
Media
91
Statuses
509
Gastrointestinal and Neuroendocrine Tumors Group (GI&NET) led by Rocío García Carbonero. Tweets by Arantza and Bea.
Madrid
Joined February 2022
Here is a must-read for all who take care of NET patients! The @ENETS_ORG statement on the management of well differentiated grade 3 NETs. As we all know, these are common cancers and quality prospective data are limited. @MGMcNamara @GCarboneroLab
https://t.co/TnF6EwZUPP
onlinelibrary.wiley.com
Grade 3 neuroendocrine tumours (NET G3) represent approximately 20% of high-grade neuroendocrine neoplasms, and the recent identification of this entity has given rise to many unanswered questions...
1
19
38
@GCarboneroLab and @DrJorgeBarriuso, thanks for allowing me to join the pic! We are a great team 😉
0
1
9
The most fun image & video creation tool in the world is here. Try it for free in the Grok App.
0
224
2K
Post Hoc Data Highlight Utility of Fruquintinib Across Metastatic Subgroups in Refractory mCRC @GCarboneroLab #ESMOGI2025 @myESMO #CRCSM
https://t.co/U3ahMqeMDb
onclive.com
Rocío García-Carbonero, MD, PhD, discusses findings from a subgroup analysis of FRESCO-2 with fruquintinib in refractory mCRC.
0
1
2
Studies Highlight Real-World Gaps in Third-Line mCRC and Evolving Role of Molecular Profiling in GI NETs @GCarboneroLab @myESMO #ESMOGI25 #oncology
https://t.co/Nu7vzxb9kH
onclive.com
Rocío García-Carbonero, MD, discusses safety challenges in third-line mCRC and the role of molecular testing in aggressive GI neuroendocrine tumors.
0
1
4
Thank you @myESMO #ESMOGI2025 chairs & organizing committee to bring GI #rarecancers to the stage and having me in good company. I hope I brought some awareness to #appendixcancers #pseudomyxoma #peritonealmesothelioma
#ESMOAmbassadors
@APeritoneum @acpmpresearch @H12Octubre
0
1
13
We had the pleasure of speaking with Rocio Garcia-Carbonero (@GCarboneroLab) at #ESMOGI25, who discussed... ⭐️ Comprehensive discussion covering FRESCO-2 subgroup analysis of fruquintinib efficacy by metastatic site ⭐️Real-world PROMETCO study findings ⭐️Role of immunotherapy
0
1
2
We caught up with Rocío García‑Carbonero, MD,@GCarboneroLab at #ESMOGI25 to discuss subgroup data from FRESCO-2 assessing the efficacy and safety of fruquintinib vs placebo across metastatic sites in mCRC 🔗 Full insights: https://t.co/OY5bBsXSeg
0
2
5
0
3
27
Poorly Differentiated Neuroendocrine Carcinomas - by @GCarboneroLab at @myESMO #ESMOGI25 👉Poorly dif 👉High Ki67 👉Agressive 🏥Chemo ASAP (PlatinumEtoposide) ✅FDG-PET (⛔️SSTR; 28% would to a Ga-PET 😫) 🤞🏻IO promising #ESMOAmbassadors @RachelRiechelm2 @Juanmaoconnor
0
20
56
Great overview of #PrecisionMedicine in #PDAC by @EileenMOReilly at @myESMO #ESMOGI25 If you missed it, please watch it 📺 🧬NGS important, with RNA for fusions 🫶KRAS 🤞🏻MTAP 👀Claudin 18.2 🤝Molecular Tumor Board-ESMO recomendations available #ESMOAmbassadors @BenWestphalen
1
33
79
My reflexions here 🧐🧐 OS benefit ✅ QoL benefit (++relevant in PDAC) ✅ No PFS benefit ❌ Is the radiological evaluation of progression in loc adv #PDAC the issue? How to solve it? 🤖Radiomics? ☢️Metabolic imaging? 🤔Any other thoughts? #ESMOGI25 #ESMOAmbassadors @myESMO
Quality of life data from #PANOVA3 (TTFields+chemo in loc adv PDAC) presented by @MacarullaTeresa at @myESMO #ESMOGI25 ✅Improved pain-free survival ✅Delayed time to global health status deterioration and opioid use #ESMOAmbassadors
1
7
14
My deepest congrats to all #YoungOncologist who secured a @myESMO #MeritTravelGrant to #ESMOGI25 Well done everyone 👏🏻👏🏻 #ESMOAmbassadors
0
2
5
We start the 2nd day of #ESMOGI25 with a Multidisciplinary Tumour Board on Rectal Cancer! #ESMOAmbassadors
0
2
4
Amazing trip through translational research in colorectal cancer from Sanger sequencing to Single Cell by @fdinicolantonio at @myESMO #ESMOGI25 #ESMOAmbassadors
0
3
6
AI revolution coming to #ESMOGI25 Very interesting presentations from Prof Magali Svrcek and @jnkath about the use and potential of #ArtificialIntelligence @myESMO #ESMOAmbassadors
1
5
13
Starting the 3rd day at #ESMOGI25 with a very interesting session showcasing selected publications of the @myESMO Gastrointestinal Oncology Journal chaired by Editors in Chief @ben_irit & Prof Lordick #ESMOAmbassadors
0
1
3
Impressive review of the use of blood based assays for screening in Colorectal Cancer at #ESMOGI25 by @FASinicropeMD Take a closer look at the takeaway points!! @myESMO #ESMOAmbassadors
0
2
6
🟢Irene Ferrer and her research journey @UAI_imas12 @CNIOStopCancer @IreneFerrerS #JornadasInvestigadoresJunior25
0
9
26
✨ Primer día de las III Jornadas Junior i+12 en el @H12Octubre Un placer presentar nuestros resultados en comunicación oral. Gracias a la organización por fomentar el intercambio y aprendizaje entre jóvenes investigadores. 🙌
1
1
5